| Literature DB >> 12847243 |
Eunice N Hatada1, Richard K G Do, Amos Orlofsky, Hsiou-Chi Liou, Michael Prystowsky, Ian C M MacLennan, Jorge Caamano, Selina Chen-Kiang.
Abstract
B lymphocyte stimulator (BLyS), a TNF family protein essential for peripheral B cell development, functions primarily through attenuation of B cell apoptosis. In this study, we show that BLyS activates NF-kappaB through both classical and alternative pathways with distinct kinetics in quiescent mature B cells. It rapidly and transiently enhances the p50/p65 DNA binding activity and induces phosphorylation of IkappaBalpha characteristic of the classical NF-kappaB pathway, albeit maintaining IkappaBalpha at a constant level through ongoing protein synthesis and proteasome-mediated destruction. With delayed kinetics, BLyS promotes the processing of p100 to p52 and sustained formation of p52/RelB complexes via the alternative NF-kappaB pathway. p50 is dispensable for p100 processing. However, it is required to mediate the initial BLyS survival signals and concomitant activation of Bcl-x(L) in quiescent mature B cells ex vivo. Although also a target of BLyS activation, at least one of the A1 genes, A1-a, is dispensable for the BLyS survival function. These results suggest that BLyS mediates its survival signals in metabolically restricted quiescent B cells, at least in part, through coordinated activation of both NF-kappaB pathways and selective downstream antiapoptotic genes.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12847243 DOI: 10.4049/jimmunol.171.2.761
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422